R-GCVP regimen
|
WikiDoc Resources for R-GCVP regimen |
|
Articles |
|---|
|
Most recent articles on R-GCVP regimen Most cited articles on R-GCVP regimen |
|
Media |
|
Powerpoint slides on R-GCVP regimen |
|
Evidence Based Medicine |
|
Clinical Trials |
|
Ongoing Trials on R-GCVP regimen at Clinical Trials.gov Trial results on R-GCVP regimen Clinical Trials on R-GCVP regimen at Google
|
|
Guidelines / Policies / Govt |
|
US National Guidelines Clearinghouse on R-GCVP regimen NICE Guidance on R-GCVP regimen
|
|
Books |
|
News |
|
Commentary |
|
Definitions |
|
Patient Resources / Community |
|
Patient resources on R-GCVP regimen Discussion groups on R-GCVP regimen Patient Handouts on R-GCVP regimen Directions to Hospitals Treating R-GCVP regimen Risk calculators and risk factors for R-GCVP regimen
|
|
Healthcare Provider Resources |
|
Causes & Risk Factors for R-GCVP regimen |
|
Continuing Medical Education (CME) |
|
International |
|
|
|
Business |
|
Experimental / Informatics |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Aparna Vuppala, M.B.B.S. [2]
Synonyms and keywords: Rituximab-Gemcitabine-Cyclophosphamide-Vincristine-Prednisone regimen
Overview
R-GCVP regimen refers to a regimen consisting of rituximab, gemcitabine, cyclophosphamide, vincristine (Oncovin), and prednisone used to treat both indolent and aggressive forms of diffuse large B-cell lymphoma.[1]
Regimen
RRituximab
GGemcitabine
CCyclophosphamide
VVincristine (Oncovin)
PPrednisone
Indications
References
- ↑ 1.0 1.1 Fields PA, Townsend W, Webb A, Counsell N, Pocock C, Smith P; et al. (2014). "De novo treatment of diffuse large B-cell lymphoma with rituximab, cyclophosphamide, vincristine, gemcitabine, and prednisolone in patients with cardiac comorbidity: a United Kingdom National Cancer Research Institute trial". J Clin Oncol. 32 (4): 282–7. doi:10.1200/JCO.2013.49.7586. PMID 24220559.